DIAGNOS Announces Closing of Private Placement
25 oct. 2024 15h45 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Oct. 25, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS Announces the Engagement of Market Maker Consultant
17 oct. 2024 15h45 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS Announces Grant of Stock Options
03 oct. 2024 15h30 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS Announces Voting Results of Meeting of Shareholders
26 sept. 2024 12h08 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Sept. 26, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS Announces Variation in One Insider Ownership
23 sept. 2024 16h29 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Sept. 23, 2024 (GLOBE NEWSWIRE) -- In accordance with regulatory requirements, Diagnos Inc. (“DIAGNOS”, the “Corporation” or the “Issuer”) (TSX Venture: ADK), announces that as a...
DIAGNOS Announces Closing of Private Placement
20 sept. 2024 15h53 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Sept. 20, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through...
DIAGNOS annonce la date de l’assemblée générale et extraordinaire des actionnaires
22 août 2024 15h45 HE
|
DIAGNOS inc.
BROSSARD, Québec, 22 août 2024 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un pionnier dans la détection précoce de...
DIAGNOS Announces Date of Annual General and Special Meeting of Shareholders
22 août 2024 15h45 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the...
DIAGNOS complète avec succès l’audit ISO 13485 / PAUMM et reçoit sa certification pour aller de l'avant avec la FDA et Santé Canada
20 août 2024 09h45 HE
|
DIAGNOS inc.
BROSSARD, Québec, 20 août 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK) (OTCQB : DGNOF), un fournisseur de services de soins de...
DIAGNOS Successfully Completes ISO 13485 / MDSAP Audit and receives its certification to move forward with FDA and Health Canada
20 août 2024 09h45 HE
|
DIAGNOS Inc.
BROSSARD, Quebec, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the...